Danville, CA, United States of America

Irwin Braude


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Vallejo, CA (US) (1992)
  • Danville, CA (US) (1990 - 1993)

Company Filing History:


Years Active: 1990-1993

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Irwin Braude: Innovator in Immunosuppressive Medicaments

Introduction

Irwin Braude is a notable inventor based in Danville, CA (US). He has made significant contributions to the field of immunology through his innovative work on medicaments derived from succinylacetone. With a total of 5 patents to his name, Braude's inventions have the potential to impact medical treatments significantly.

Latest Patents

Braude's latest patents focus on immunosuppressive analogues and derivatives of succinylacetone. These patents detail the synthesis of medicaments that include succinylacetonyl-proline-PEG and succinylacetonyl-NH-PEG. The compounds described in his patents exhibit immunosuppressive activity both in vivo and in vitro, demonstrating their effectiveness in cellular immunologic assays and in models of adjuvant-induced arthritis in rats.

Career Highlights

Irwin Braude has had a distinguished career, working at Cetus Corporation, where he has been able to apply his expertise in developing innovative medical solutions. His work has contributed to advancements in the treatment of various immunological conditions.

Collaborations

Throughout his career, Braude has collaborated with notable colleagues, including Corey H. Levenson and Danute E. Nitecki. These collaborations have further enriched his research and development efforts in the field of immunology.

Conclusion

Irwin Braude's contributions to the field of immunology through his patents on succinylacetone derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…